Ferah Comert Onder

11PUBLICATIONS
11CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 27, 2026
Targeting p53-Driven FOXM1 Suppresses Tumor Growth and Synergistically Sensitizes to Chemotherapy in Triple-Negative Breast Cancer Models.

|Jul 21, 2026
Design, synthesis, biological evaluation, and in silico analysis of novel coumarin carboxamides as acetylcholinesterase and butyrylcholinesterase inhibitors and anticancer agents.

|Jun 23, 2026
Discovery of potential AXL inhibitors using virtual screening, molecular docking, molecular dynamics, molecular mechanics, and in vitro validation.

|May 03, 2026
Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity Relationship.

|Jul 16, 2025
Design, synthesis, characterization, in silico studies, and in vitro anticancer evaluation of novel 7-methoxyquinolone-substituted triazole hybrids.

Lemıye Allıto, Ferah Comert Onder, Ramazan Demirel

|Jul 02, 2025
New and potential boron-containing compounds for treatment of Alzheimer's disease and cancers.

Ferah Comert Onder, Kadircan Ural, Alper Onder

Pageof 2

Frequent Collaborators

4 joint publications

Alper Onder

2 joint publications

Musa Erdoğan

2 joint publications

Merve Sıkık

2 joint publications

Mehmet Ay